LPC

Lion Point Capital Portfolio holdings

AUM $16.7M
1-Year Est. Return 119.35%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+119.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7M
AUM Growth
-$2.59M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1 +$156K
2 +$148K
3 +$114K

Top Sells

1 +$391K
2 +$375K
3 +$141K
4
MRSN
Mersana Therapeutics
MRSN
+$2.89K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$9.34B
$1.43M 8.57%
4,450
MLTX icon
2
MoonLake Immunotherapeutics
MLTX
$1.39B
$1.26M 7.52%
67,500
RPRX icon
3
Royalty Pharma
RPRX
$24.5B
$1.03M 6.14%
21,400
MIST icon
4
Milestone Pharmaceuticals
MIST
$169M
$976K 5.83%
820,000
+65,000
GERN icon
5
Geron
GERN
$776M
$861K 5.15%
578,000
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$1.67B
$841K 5.03%
36,000
ARDX icon
7
Ardelyx
ARDX
$1.42B
$771K 4.61%
128,650
FENC icon
8
Fennec Pharmaceuticals
FENC
$343M
$691K 4.13%
112,434
BNTC icon
9
Benitec Biopharma
BNTC
$372M
$660K 3.95%
62,000
SRPT icon
10
Sarepta Therapeutics
SRPT
$1.86B
$620K 3.71%
28,500
IRON icon
11
Disc Medicine
IRON
$2.75B
$518K 3.1%
8,100
CUE icon
12
Cue Biopharma
CUE
$97.4M
$506K 3.03%
73,428
CMPS
13
Compass Pathways
CMPS
$1.91B
$442K 2.64%
80,000
+22,000
BHVN icon
14
Biohaven
BHVN
$1.72B
$437K 2.61%
51,700
LNTH icon
15
Lantheus
LNTH
$6.32B
$417K 2.49%
5,500
JSPR icon
16
Jasper Therapeutics
JSPR
$15M
$407K 2.44%
465,000
HUMA icon
17
Humacyte
HUMA
$322M
$394K 2.36%
650,000
+150,000
VTRS icon
18
Viatris
VTRS
$18.4B
$374K 2.24%
27,700
KURA icon
19
Kura Oncology
KURA
$803M
$374K 2.24%
46,000
BBIO icon
20
BridgeBio Pharma
BBIO
$12.8B
$371K 2.22%
5,000
DYN icon
21
Dyne Therapeutics
DYN
$3.08B
$326K 1.95%
18,000
RCKT icon
22
Rocket Pharmaceuticals
RCKT
$330M
$308K 1.84%
86,000
PCRX icon
23
Pacira BioSciences
PCRX
$903M
$305K 1.82%
13,500
EWTX icon
24
Edgewise Therapeutics
EWTX
$4.33B
$287K 1.71%
9,100
MLYS icon
25
Mineralys Therapeutics
MLYS
$2.57B
$284K 1.7%
10,500